Evaluation of anxiolytic effect of furosemide in Albino rats
Keywords:Anxiety disorders, Actophotometer, Elevated plus maze, Furosemide
Background: Anxiety disorders are the most prevalent class of psychiatric condition. Medications commonly given for treatment can elicit several central nervous system (CNS) side-effects that patients find difficult to tolerate. So there is a need for new pharmacotherapeutic approaches to treat anxiety with greater efficacy and fewer side effects. Hence this study has been taken up to evaluate the anxiolytic effect of furosemide at three different doses (75mg/kg, 150mg/kg and 200mg/kg) in Albino rats.
Methods: After obtaining approval from the institutional animal ethical committee 30 Albino rats weighing about 150-200gm were taken and divided into 5 groups of 6 rats each. Group 1: Normal Saline 10ml/kg (control); Group 2: Diazepam 2mg/kg (standard); Group 3: Furosemide 150mg/kg (test group 1); Group 4: Furosemide 200mg/kg (test group 2); Group 5: Furosemide 75mg/kg + Diazepam 1mg/kg (sub threshold dose). The anxiolytic activity of furosemide was tested by elevated plus maze and digital actophotometer models. Data was analysed using one way ANOVA followed by Posthoc Tukey’s test.
Results: Furosemide (150mg/kg and 200mg/kg) have shown significant increase in open arm entries (p<0.05) and time spent in open arm (p<0.05) compared to control. Also furosemide (150mg/kg and 200mg/kg) have shown statistically significant decrease in locomotor activity (p<0.05) compared to control in actophotometer model. Potentiation of time spent and number of entries in open arm and decrease in locomotor activity were noticed when sub threshold doses of combination of diazepam and furosemide were used.
Conclusions: These results suggest that furosemide possesses significant anxiolytic activity at both the doses. Furosemide given in sub threshold dose potentiates the antianxiety effect of sub threshold dose of diazepam when used in combination. Hence, after further studies, furosemide can be used as an anxiolytic drug.
Remes O, Brayne C, Linde R, Lafortune L. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain and behavior. 2016 Jul 1;6(7).
American Psycology Association [Internet] [Cited 12/01/17]. Available at: http://www.apa.org/topic/anxiety.
Krystal A, Sutherland J, Hochman W. Loop diuretics have anxiolytic effects in rat models of conditioned anxiety. PLoS ONE. 2012 April;7(4):e35417.
Mahendra P, Bisht S. Anti-anxiety activity of Coriandrum sativum assessed using different experimental anxiety models. Indian J Pharmacol. 2011;43(5):574-7.
Lydiard RB. The role of gaba in anxiety disorders. J Clin Psychiatry. 2003;64(3):21-7.
Russell JM. Sodium-potassium-chloride cotransport. Physiological Reviews. 2000;80:211-76.
Blaesse P, Airaksinen MS, Rivera C, Kaila K. Cation-chloride cotransporters and neuronal function. Neuron. 2009;61:820-38.
Chen H, Sun D. The role of Na-K-Cl co-transporter in cerebral ischemia. Neurol Res. 2005;27:280-6.
Jayakumar AR, Norenberg MD. The Na-K-Cl co-transporter in astrocyte swelling. Metab Brain Dis. 2010;25:31-8.
MacVicar BA, Feighan D, Brown A, Ransom B. Intrinsic optical signals in the rat optic nerve: role for K(+) uptake via NKCC1 and swelling of astrocytes. Glia. 2002;37:114-23.
Fernandez-robles C, Stern TA, Caro MA, Huffman JC; Pharmacological aspects. Dialogues Clin. Neurosci. 2011;13:109-25.
Kulkarni SK. Delhi: Vallabh Prakashan; Handbook of Experimental Pharmacology; 1999:135-137.
Halemani D. Evaluation of anti-anxiety activity of methanol extract of aegle maemelos (Bael fruit tree) leaves in rats. IOSR-JDMS. Sept 2015;14(9):01-5.
Whiteford, Harvey A, Degenhardt L, Jurgem R, Baxter AJ. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575-86.